FI893428A0 - ELIMINERING AV TOXISKA EGENSKAPER IN VITRO OCH IN VIVO HOS TNF-A MEDELST MONOCLONALA ANTIKROPPAR OCH FRAGMENT HAERLEDDA FRAON DESSA. - Google Patents
ELIMINERING AV TOXISKA EGENSKAPER IN VITRO OCH IN VIVO HOS TNF-A MEDELST MONOCLONALA ANTIKROPPAR OCH FRAGMENT HAERLEDDA FRAON DESSA.Info
- Publication number
- FI893428A0 FI893428A0 FI893428A FI893428A FI893428A0 FI 893428 A0 FI893428 A0 FI 893428A0 FI 893428 A FI893428 A FI 893428A FI 893428 A FI893428 A FI 893428A FI 893428 A0 FI893428 A0 FI 893428A0
- Authority
- FI
- Finland
- Prior art keywords
- och
- toxiska
- monoclonala
- haerledda
- eliminering
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3823804A DE3823804A1 (en) | 1988-07-14 | 1988-07-14 | NEUTRALIZATION OF THE TOXIC PROPERTIES OF TNF- (ALPHA) IN VITRO AND VIVO BY MONOCLONAL ANTIBODIES AND THE FRAGMENTS DERIVED FROM THEM |
Publications (2)
Publication Number | Publication Date |
---|---|
FI893428A0 true FI893428A0 (en) | 1989-07-14 |
FI893428A FI893428A (en) | 1990-01-15 |
Family
ID=6358617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI893428A FI893428A (en) | 1988-07-14 | 1989-07-14 | ELIMINERING AV TOXISKA EGENSKAPER IN VITRO OCH IN VIVO HOS TNF-A MEDELST MONOCLONALA ANTIKROPPAR OCH FRAGMENT HAERLEDDA FRAON DESSA. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0350690A3 (en) |
JP (1) | JPH02109994A (en) |
DE (1) | DE3823804A1 (en) |
DK (1) | DK346789A (en) |
FI (1) | FI893428A (en) |
ZA (1) | ZA895325B (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9028123D0 (en) * | 1990-12-28 | 1991-02-13 | Erba Carlo Spa | Monoclonal antibodies against human tumor necrosis factor alpha |
US6277969B1 (en) | 1991-03-18 | 2001-08-21 | New York University | Anti-TNF antibodies and peptides of human tumor necrosis factor |
US5919452A (en) * | 1991-03-18 | 1999-07-06 | New York University | Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies |
US5656272A (en) * | 1991-03-18 | 1997-08-12 | New York University Medical Center | Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies |
US7192584B2 (en) | 1991-03-18 | 2007-03-20 | Centocor, Inc. | Methods of treating psoriasis with anti-TNF antibodies |
ES2289997T3 (en) * | 1991-03-18 | 2008-02-16 | New York University | SPECIFIC MONOCLONAL AND CHEMICAL ANTIBODIES FOR THE HUMAN TUMOR NECROSIS FACTOR. |
US6284471B1 (en) * | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
WO1994029347A1 (en) * | 1993-06-03 | 1994-12-22 | Therapeutic Antibodies Inc. | Antibody fragments in therapy |
AU703091B2 (en) * | 1995-08-04 | 1999-03-18 | Lek Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. | Monoclonal antibodies against soluble TNF-alpha receptors p55 and p75 as well as against TNF-alpha and its analogues |
GB9517538D0 (en) * | 1995-08-26 | 1995-10-25 | Therapeutic Antibodies Inc | Production and therapeutic combinations, of antibodies |
UA81743C2 (en) | 2000-08-07 | 2008-02-11 | Центокор, Инк. | HUMAN MONOCLONAL ANTIBODY WHICH SPECIFICALLY BINDS TUMOR NECROSIS FACTOR ALFA (TNFα), PHARMACEUTICAL MIXTURE CONTAINING THEREOF, AND METHOD FOR TREATING ARTHRITIS |
TWI334439B (en) | 2001-08-01 | 2010-12-11 | Centocor Inc | Anti-tnf antibodies, compositions, methods and uses |
EP1578799B8 (en) | 2002-12-02 | 2011-03-23 | Amgen Fremont Inc. | Antibodies directed to tumor necrosis factor and uses thereof |
RU2010107994A (en) * | 2007-08-08 | 2011-09-20 | Эбботт Лэборетриз (Us) | COMPOSITIONS AND METHODS OF CRYSTALLIZING ANTIBODIES |
US8415291B2 (en) | 2008-10-31 | 2013-04-09 | Centocor Ortho Biotech Inc. | Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses |
US10465003B2 (en) | 2016-02-05 | 2019-11-05 | Janssen Biotech, Inc. | Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes |
WO2018140121A1 (en) | 2017-01-30 | 2018-08-02 | Janssen Biotech, Inc. | Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis |
KR20240038148A (en) | 2017-02-07 | 2024-03-22 | 얀센 바이오테크 인코포레이티드 | Anti-tnf antibodies, compositions, and methods for the treatment of active ankylosing spondylitis |
CN113874073A (en) | 2019-05-23 | 2021-12-31 | 詹森生物科技公司 | Methods of treating inflammatory bowel disease with combination therapy of antibodies to IL-23 and TNF α |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3631229A1 (en) * | 1986-09-13 | 1988-03-24 | Basf Ag | MONOCLONAL ANTIBODIES AGAINST HUMAN TUMORNESCROSE FACTOR (TNF) AND THEIR USE |
AU4182289A (en) * | 1988-08-19 | 1990-03-23 | Celltech Limited | Pharmaceutical products for anti-neoplastic therapy |
-
1988
- 1988-07-14 DE DE3823804A patent/DE3823804A1/en not_active Withdrawn
-
1989
- 1989-06-24 EP EP89111538A patent/EP0350690A3/en not_active Withdrawn
- 1989-07-13 ZA ZA895325A patent/ZA895325B/en unknown
- 1989-07-13 DK DK346789A patent/DK346789A/en not_active Application Discontinuation
- 1989-07-14 JP JP1180674A patent/JPH02109994A/en active Pending
- 1989-07-14 FI FI893428A patent/FI893428A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI893428A (en) | 1990-01-15 |
DK346789D0 (en) | 1989-07-13 |
EP0350690A3 (en) | 1990-07-04 |
DK346789A (en) | 1990-01-15 |
DE3823804A1 (en) | 1990-01-18 |
ZA895325B (en) | 1991-04-24 |
JPH02109994A (en) | 1990-04-23 |
EP0350690A2 (en) | 1990-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI893428A0 (en) | ELIMINERING AV TOXISKA EGENSKAPER IN VITRO OCH IN VIVO HOS TNF-A MEDELST MONOCLONALA ANTIKROPPAR OCH FRAGMENT HAERLEDDA FRAON DESSA. | |
FI886048A (en) | FOERFARANDE OCH ANORDNING FOER BEROERINGSFRI AKUSTISK TESTNING AV ELASTICITETEN HOS MJUK BIOLOGISK VAEVNAD. | |
DE69010330T2 (en) | FIBROBLAST GROWTH FACTOR CONJUGATES. | |
FI873035A0 (en) | FOERFARANDE OCH ARRANGEMANG FOER OPTIMERING AV FUNKTIONEN HOS EN DOERRSTAENGARE. | |
FI900433A0 (en) | FOERFARANDE OCH ANORDNING FOER REGLERING AV PROFILJAEMNHETEN HOS EN MATERIALBANA. | |
DE69007311D1 (en) | Conjugates. | |
FI874863A (en) | FOERFARANDE OCH ANORDNING FOER FOERBAETTRING AV VERKNINGSGRADEN HOS EN MOTORSTYRD HYDRAULHISS. | |
FI883335A (en) | FOERFARANDE OCH ANORDNING FOER BESTAEMMANDE AV ROTORRESISTENSEN HOS EN VRIDFAELTMASKIN. | |
FI891131A0 (en) | SULFATERAD K5-ANTIGEN OCH SULFATERADE FRAGMENT AV K5-ANTIGEN. | |
FI904447A0 (en) | SUBSTITUTE ISOKINOLINER OCH FOERFARANDEN FOER DERAS ANVAENDNING. | |
FI881348A0 (en) | FOERFARANDE OCH ANORDNING FOER EFFEKTIVERING AV FUNKTIONEN HOS SKIVFILTER. | |
FI893545A0 (en) | MAENSKANS PROTEIN C-MUTANTER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING. | |
FI895593A0 (en) | ANORDIN I SYNNERHET FOER BEHANDLING AV KRAEMER OCH PASTOR. | |
FI895749A (en) | FOERFARANDE OCH ANORDNING I EN PAPPERSMASKIN. | |
FI895893A (en) | MODIFIED VISKOSFIBRER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING. | |
FI883637A (en) | FOERFARANDE OCH ANORDNING FOER MAETNING AV DAGGPUNKTEN HOS GASER. | |
FI884805A0 (en) | FOERFARANDE OCH ANORDNING FOER REGLERING AV FUKTIGHETSGRADEN HOS LOESGODSMATERIAL. | |
FI880681A0 (en) | FOERFARANDE FOER OEKNING IN VITRO AV FORTPLANTNINGSEFFEKTIVITETEN HOS POTATIS. | |
FI890869A (en) | SUBSTITUTE IMIDAZOLINONER OCH IMIDAZOLINTIONER. | |
FI881480A0 (en) | FOERFARANDE OCH ANORDNING FOER INDRAGNING AV EN PAPPERSBANA IN EN RULLNINGSMASKIN. | |
FI893360A0 (en) | FOERFARANDE OCH ANORDNING FOER REGLERING AV BLADPROFILEN HOS EN BLADSCHABER. | |
FI893283A0 (en) | FOERFARANDE FOER BESTAEMNING AV VRIDMOMENT OCH EFFEKT HOS AXLAR. | |
FI891291A0 (en) | FOERFARANDE OCH ANORDNING FOER REGLERING AV ARBETSDJUPET HOS EN TORVFRAES. | |
FI895736A0 (en) | FOERFARANDE OCH ANORDNING FOER FOERVARING AV FLYTANDE TVAETTMEDEL UNDER ANVAENDNING. | |
FI893373A (en) | FOERFARANDE OCH AVGRENINGSSTYCKE FOER AVGRENING AV AVLOPPSROER UNDER SANERING. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed | ||
FD | Application lapsed |
Owner name: BASF AKTIENGESELLSCHAFT |